kisspeptin-52



kisspeptin-52

S1SS1S2SS2P3PP3C4CC4P5PP5P6PP6V7VV7E8EE8G9GG9P10PP10A11AA11G12GG12R13RR13Q14QQ14R15RR15P16PP16L17LL17C18CC18A19AA19S20SS20R21RR21S22SS22R23RR23L24LL24I25II25P26PP26A27AA27P28PP28R29RR29G30GG30A31AA31V32VV32L33LL33V34VV34Q35QQ35R36RR36E37EE37K38KK38D39DD39L40LL40S41SS41T42TT42Y43YY43N44NN44W45WW45N46NN46S47SS47... and 5 more residue(s)...... and 5 more residue(s)

SMILES None
InChIKey None
Sequence SSPCPPVEGPAGRQRPLCASRSRLIPAPRGAVLVQREKDLSTYNWNSFGLRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

kisspeptin-52

S1SS1S2SS2P3PP3C4CC4P5PP5P6PP6V7VV7E8EE8G9GG9P10PP10A11AA11G12GG12R13RR13Q14QQ14R15RR15P16PP16L17LL17C18CC18A19AA19S20SS20R21RR21S22SS22R23RR23L24LL24I25II25P26PP26A27AA27P28PP28R29RR29G30GG30A31AA31V32VV32L33LL33V34VV34Q35QQ35R36RR36E37EE37K38KK38D39DD39L40LL40S41SS41T42TT42Y43YY43N44NN44W45WW45N46NN46S47SS47... and 5 more residue(s)...... and 5 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.